» Articles » PMID: 22362355

Nitric Oxide Release: Part I. Macromolecular Scaffolds

Overview
Journal Chem Soc Rev
Specialty Chemistry
Date 2012 Feb 25
PMID 22362355
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

The roles of nitric oxide (NO) in physiology and pathophysiology merit the use of NO as a therapeutic for certain biomedical applications. Unfortunately, limited NO payloads, too rapid NO release, and the lack of targeted NO delivery have hindered the clinical utility of NO gas and low molecular weight NO donor compounds. A wide-variety of NO-releasing macromolecular scaffolds has thus been developed to improve NO's pharmacological potential. In this tutorial review, we provide an overview of the most promising NO release scaffolds including protein, organic, inorganic, and hybrid organic-inorganic systems. The NO release vehicles selected for discussion were chosen based on their enhanced NO storage, tunable NO release characteristics, and potential as therapeutics.

Citing Articles

Anti-Infective Bacteriophage Immobilized Nitric Oxide-Releasing Surface for Prevention of Thrombosis and Device-Associated Infections.

Gondil V, Ashcraft M, Ghalei S, Kumar A, Wilson S, Devine R ACS Appl Bio Mater. 2025; 8(2):1362-1376.

PMID: 39895136 PMC: 11836933. DOI: 10.1021/acsabm.4c01638.


Cascade-catalysed nanocarrier degradation for regulating metabolism homeostasis and enhancing drug penetration on breast cancer.

Zhang F, Cheng K, Zhang X, Zhou S, Zou J, Tian M J Nanobiotechnology. 2024; 22(1):680.

PMID: 39506777 PMC: 11542379. DOI: 10.1186/s12951-024-02948-w.


Injectable polysaccharide hydrogels as localized nitric oxide delivery formulations.

Feura E, Maloney S, Conlon I, Broberg C, Yang F, Schoenfisch M Adv Mater Technol. 2024; 8(7).

PMID: 39211298 PMC: 11361346. DOI: 10.1002/admt.202201529.


Near-infrared light-responsive Nitric oxide microcarrier for multimodal tumor therapy.

Liang D, Kuang G, Chen X, Lu J, Shang L, Sun W Smart Med. 2024; 2(3):e20230016.

PMID: 39188343 PMC: 11236066. DOI: 10.1002/SMMD.20230016.


Delivery of Nitric Oxide by Chondroitin Sulfate C Increases the Rate of Wound Healing through Immune Modulation.

Picciotti S, El-Ahmad H, Bucci M, Grayton Q, Wallet S, Schoenfisch M ACS Appl Bio Mater. 2024; 7(9):6152-6161.

PMID: 39159191 PMC: 11546757. DOI: 10.1021/acsabm.4c00731.


References
1.
Riccio D, Nugent J, Schoenfisch M . Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles. Chem Mater. 2011; 23(7):1727-1735. PMC: 3075092. DOI: 10.1021/cm102510q. View

2.
Katsumi H, Nishikawa M, Yamashita F, Hashida M . Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-Nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo. J Pharmacol Exp Ther. 2005; 314(3):1117-24. DOI: 10.1124/jpet.105.087429. View

3.
Frost M, Meyerhoff M . Controlled photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized fumed silica filler. J Am Chem Soc. 2004; 126(5):1348-9. DOI: 10.1021/ja039466i. View

4.
Coneski P, Rao K, Schoenfisch M . Degradable nitric oxide-releasing biomaterials via post-polymerization functionalization of cross-linked polyesters. Biomacromolecules. 2010; 11(11):3208-15. PMC: 3070196. DOI: 10.1021/bm1006823. View

5.
Ewing J, Young D, Janero D, Garvey D, Grinnell T . Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners. J Pharmacol Exp Ther. 1997; 283(2):947-54. View